— Know what they know.
Not Investment Advice

RYTM NASDAQ

Rhythm Pharmaceuticals, Inc.
1W: -3.7% 1M: +5.9% 3M: -9.6% YTD: -14.1% 1Y: +41.2% 3Y: +447.6% 5Y: +300.0%
$87.84
-2.35 (-2.61%)
 
Weekly Expected Move ±7.6%
$77 $84 $91 $97 $104
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 58 · $6.0B mcap · 56M float · 1.57% daily turnover · Short 61% of daily vol

📊 Key Metrics

TTM
$217M
Revenue
+58.7% YoY
$-203M
Net Income
-20.1% YoY
$-120M
Free Cash Flow
-6.1% YoY
88.1%
Gross Margin
-87.1%
Op. Margin
-92.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-133.5%
ROA-46.4%
ROIC4576.6%

Valuation

P/E-29.5
P/B48.6
EV/EBITDA-31.6

Leverage

Debt/Equity1.77
Current Ratio4.41
Interest Cov.-9.3x

Quality Scores

Piotroski F4/9
Altman Z6.53
Beneish M-2.84

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms